Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...

Question: I paid so much for my Eliquis this year, will I have to pay that much next year too? Answer: The good news is no, seniors will not pay as much for Eliquis as well as nine other common ...

A recent op-ed does not recognize the important work of the Maryland Prescription Drug Affordability Board, writes Vincent ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray showed promising effects on cognition and biomarkers ...

The latest edition of the Patented Medicine Prices Review Board (PMPRB) CompassRx report shows that prescription drug expenditure for public drug plans grew by 7.4% in 2022/23 to reach $14.1 billion, ...

In Q3, the top 10 TV ad spenders poured a combined $544.8 million into airing their commercials, according to data shared ...

Eli Lilly is expected to present third-quarter results on Oct. 30 after the market opens. Wall Street analysts will be ...

Ipca Laboratories was named in a patent infringement lawsuit on Sept. 29 in Delaware District Court over its plans to market generic versions of the diabetes medication Jardiance. The action, brought ...

The 2026 Part D plans became available to the public Oct. 1 at Medicare.gov, and there are serious changes, with Part D ...

In a study from Korea, adults with type 2 diabetes had a lower risk for autoimmune rheumatic diseases after starting an SGLT2 ...